Digital health company, AEYE Health, has developed an AI-based retinal screening system that provides analysis and diagnostic results within 60 seconds.
Retinal diseases such as diabetic retinopathy (DR), glaucoma, macular degeneration and hypertensive retinopathy are becoming more frequent. Over a billion people worldwide are at high risk for loss of sight and require an annual retinal check.
Only 25% of high-risk patients are screened for retinal diseases due to high costs and lack of access to retinal screening.
Tel-Aviv-based AEYE Health aims to simplify the screening process by creating an advanced AI diagnostic system, which can operate on any fundus camera. This will enable the screenings to take place outside the ophthalmologist’s office, in places like primary care and endocrinology clinics or pharmacies.
AEYE Health’s machine learning and artificial-intelligence technologies aims to offer instant and accurate screening and analysis of the retina for the detection of a variety of conditions, including Alzheimer's disease and heart conditions.
AEYE Health was founded in 2018 by Zack Dvey-Aharon, a machine learning expert, and by COO Danny Margalit, former founding partner of Aladdin Knowledge Systems.
Zack Dvey-Aharon, co-founder and CEO of AEYE Health, said: “Early detection is key to saving patients’ vision. We at AEYE Health have created a unique, AI-based system that can operate on any fundus camera to ensure patients who need an eye check can receive it without having to wait until their next visit to the ophthalmologist’s office.
“We are currently on track to receive our FDA approval by the end of the year. We already have several exciting projects in the pipeline, ready for launch as soon as we get the clearance.
“We are delighted to spearhead global efforts to develop an accurate, affordable and useable solution to detect retinal conditions, prevent blindness and save lives.”
